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Abstract
Predicating macroscopic influences of drugs on human body,
like efficacy and toxicity, is a central problem of small-
molecule based drug discovery. Molecules can be represented
as an undirected graph, and we can utilize graph convolu-
tion networks to predication molecular properties. However,
graph convolutional networks and other graph neural net-
works all focus on learning node-level representation rather
than graph-level representation. Previous works simply sum
all feature vectors for all nodes in the graph to obtain the
graph feature vector for drug predication. In this paper, we in-
troduce a dummy super node that is connected with all nodes
in the graph by a directed edge as the representation of the
graph and modify the graph operation to help the dummy
super node learn graph-level feature. Thus, we can handle
graph-level classification and regression in the same way as
node-level classification and regression. In addition, we ap-
ply focal loss to address class imbalance in drug datasets.
The experiments on MoleculeNet show that our method can
effectively improve the performance of molecular properties
predication.
Introduction
Reducing the high attrition rates in drug development con-
tinues to be a key challenge for the pharmaceutical industry.
When biological researches yield evidence that a particular
molecule could modulate essential pathways to achieve ther-
apeutic activity, the discovered molecule often fails as a po-
tential drug for a number of reasons including toxicity, low
activity, and low solubility(Waring et al. 2015). The primary
problem of small-molecule based drug discovery is finding
analogue molecules with increased efficacy and reduced safe
risks to the patient to optimize the candidate molecule. Ma-
chine learning is a powerful tool of drugs virtual screening
that can help drug developer eliminate unqualified candidate
molecules quickly.
A molecule can be of arbitrary size and shape. How-
ever, most machine learning methods can only handle in-
puts of a fixed size. A wide-used conventional proposal is
to utilize hand-crafted feature like ECFP(Rogers and Hahn
2010), Coulomb Matrix(Rupp et al. 2012) as input and feed
it into conventional classifier like random forest and multi-
layer perceptron. In the last few years, convolutional neu-
ral network clearly surpassed the conventional methods that
use hand-crafted feature and SVM in object classification
tasks(Krizhevsky, Sutskever, and Hinton 2012). It indicates
that end-to-end learning with reasonable differentiable fea-
ture extractor may surpass the conventional two stage clas-
sifier. Following this idea, (Duvenaud et al. 2015) model a
molecule as a graph, the nodes of which stand for atoms and
the edges of which represent chemical bonds linking some
of the atoms together, and propose graph convolutional net-
work which directly takes the graph as input to learn the rep-
resentations of molecules. Previous studies show that graph
convolutional network broadly offers the best performance
in most of the datasets in MoleculeNet(Wu et al. 2017).
Molecular properties of drugs are almost macroscopic in-
fluences on human body, like efficacy and toxicity. In fact,
unlike common graph-based application like web classifi-
cation, citation network and knowledge graph, predicating
drugs properties is graph-level classification and regression
rather than node-level classification and regression. How-
ever, present graph neural networks, including graph convo-
lutional network(Duvenaud et al. 2015), similar graph net-
works that take the original molecule as input(Altae-Tran
et al. 2017; Yao et al. 2017; Schu¨tt et al. 2017; Gomes et
al. 2017), and other general graph neural networks designed
for all types of graph(Li et al. 2015; Bruna et al. 2013;
Defferrard, Bresson, and Vandergheynst 2016; Kipf and
Welling 2016; Niepert, Ahmed, and Kutzkov 2016), all fo-
cus on learning node-level representation rather than graph-
level representation. Previous works (Altae-Tran et al. 2017;
Wu et al. 2017) simply sums all feature vectors for all nodes
in the graph to obtain the graph representation for molecule
properties classification and regression.
To learn better graph-level representation and handle
graph-level classification and regression, we introduce a
dummy super node that is connected with all nodes in the
graph by a directed edge, as the representation of the graph.
Thus, we can handle graph-level classification and regres-
sion in the same way as node-level classification and regres-
sion. The idea of taking the feature of one specific node as
the feature of the graph has been proposed before(Scarselli
et al. 2009), but earlier work simply assign the first atom in
the atom-bond description as the specific node. In our work,
the dummy super node is initialized to zero and get updated
through graph convolutional networks simultaneously as the
genuine nodes do. We modify the graph operations(Altae-
Tran et al. 2017) and apply node-level batch normalization
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to learn better features. We take the feature of the dummy
super node as the feature of the graph and feed it into classi-
fier.
Another problem of molecular properties predication is
that the datasets of molecules are often unbalanced. That
is, the positive samples may be only a small part of the
total samples. Take HIV dataset(hiv ) as instance, there
are only 1487 chemical compounds that are HIV active in
the dataset of totally 41913 chemical compounds. Previous
works(Altae-Tran et al. 2017; Wu et al. 2017) did not pay
much attention to the fact of unbalanced data. To address
the unbalanced data, we adopt focal loss(Lin et al. 2017)
and show that it can effectively improve the classification
performance in unbalanced molecular dataset.
We evaluated our model on several datasets of toxity, bi-
ological activities and solubility in MoleculeNet, including
Tox21 ToxCast, PCBA, MUV, HIV, FreeSolv. The results
show that our method could effectively improve the perfor-
mance on molecular properties predication.
Related Work
Our work draws inspiration both from the field of molecular
machine learning and graph neural network. In what follows,
we provide a brief overview of previous works in both fields.
Molecule Mchine Learning
Encoding molecules into fixed-length strings or vectors is
a core challenge for molecular machine learning. (Rupp et
al. 2012) introduce Coulomb Matrix as feature of molecules
and apply a machine learning model to predict atomiza-
tion energies of a diverse set of organic molecules. (Rogers
and Hahn 2010) propose Extended-connectivity fingerprints
(ECFP), a novel class of topological fingerprints for molec-
ular characterization.
(Duvenaud et al. 2015) propose graph convolutional net-
work that operates directly on graph, which could learn
better representations than conventional method like ECFP.
(Altae-Tran et al. 2017) combine graph convolutional net-
work with residual LSTM embedding for one-shot learning
on drug discovery. (Yao et al. 2017; Schu¨tt et al. 2017) ap-
ply neural network to predicate the molecular energy and
reduced the predication error to 1 kcal/mol. (Gomes et al.
2017) propose atomic neural network to predicate the bind-
ing free energy of a subset of protein-ligand complexes
found in the PDBBind dataset.(Ramsundar et al. 2015) ap-
plied Massively multitask neural architectures to synthesize
information from many distinct biological sources. (Wu et
al. 2017) introduce MoleculeNet, a large scale benchmark
for molecular machine learning, which contains multiple
public datasets, and establish metrics for evaluation and high
quality open-source implementations.
Graph neural network
Graph-based Neural networks have previously introduced
in(Gori, Monfardini, and Scarselli 2005; Scarselli et al.
2009) as a form of recurrent neural network. (Li et al. 2015)
modify the graph neural network by using gated recurrent
units and modern optimization techniques and then extend to
output sequences. Spectral graph convolutional neural net-
works are introduced by (Bruna et al. 2013) and later ex-
tended by (Defferrard, Bresson, and Vandergheynst 2016)
with fast localized convolutions. (Kipf and Welling 2016) in-
troduced a number of simplifications to spectral graph con-
volutinal neural network and improve scalibility and classi-
fication performance in large-scale networks. (Cao, Lu, and
Xu 2016) propose a novel model for learning graph repre-
sentations, which generates a low-dimensional vector repre-
sentation for each vertex by capturing the graph structural
information. (Niepert, Ahmed, and Kutzkov 2016) propose
a framework for learning convolutional neural networks for
arbitrary graphs and applied it to molecule classification.
All above work focus on learning node-level representa-
tion in graph rather than graph-level representation. How-
ever, predicating molecular properties is in fact a problem of
graph-level classification and regression. In this paper, we
introduce a dummy super node that is connected to all other
nodes by a directed edge to learn graph-level representation
rather than simply using the sum of the vectors of all nodes
as the graph-level representation(Duvenaud et al. 2015;
Altae-Tran et al. 2017).
Learning Graph-Level Representation
For most macroscopic molecular properties predication
tasks, like efficacy and toxicity, we could neglect the de-
tailed edge information and take a molecule as an undirected
graph(Wu et al. 2017). We apply graph convolutional net-
works(Duvenaud et al. 2015) to learn representation of the
atoms(nodes) in the molecule. To learn the representation of
the molecule(graph), we introduce a dummy super node that
is connected with all nodes in the graph by a directed edge.
We modify the graph operation to help the dummy super
node learn graph-level feature, and utilize neural network as
a classifier for graph-level properties predication.
Graph Convolutional Network
A molecule could be modeled as a graph, the nodes of which
stand for atoms and the edges of which represent chemical
bonds linking some of the atoms together. In graph convolu-
tion network, for a specific node, we separately feed it and
its neighbours into two dense layer, and calculate the sum
as the new features of the node. The weights are shared be-
tween dense layers that operate on different node with the
same degree. Formally, for a specific node v, that have to-
tally d neighbours ni(1 ≤ i ≤ d), the new feature of the
node v′ of graph convolution operation is formulated as
v′ =W dselfv +
∑
1≤i≤d
W dnbni + bd (1)
where W dself is the weight for self node, W
d
nb is the
weight for neighbour node, boldsymbolbd is the bias. These
weights vary from different degree d of the specific node,
for that the nodes with different number of neighbours are
affected by neighbours in different ways. Since the output
of graph convolution layer is also a graph, we could contin-
ually apply graph convolution layers to the graph. Thus, the
receptive field of the network would be larger, and the nodes
GraphConv GraphConv(Super Node) GraphPool
v v
S
S
S
S
v and its neighbors are fed
into dense layer and summed
S and all nodes are fed
into dense layer and summed
Max over v and its neighbors
Figure 1: Graphical representation of the major graph operation. The dark blue node represents the specific node v, the
light blue nodes represent the neighbours of v, the dotted node represents the dummy super node S. The orange and yellow
arrows represent dense layer with different weights. The red arrows represent max polling, the black arrow represents identical
mapping. The dummy super node is connected with all other nodes by a directed edge. The directed edge indicates that the
dummy super node learns feature from genuine nodes but does not affect the feature of genuine nodes. Note that, for GraphConv
and GraphPool, the operation is shown for a single node v, however, these operations are performed on all nodes in graph
simultaneously in fact.
would be affected by further neighbours. The left thumbnail
in figure illustrates the graph convolution operation. The
yellow arrows indicate the dense layer with weight W dnb for
neighbours, representing the neighbours’ effect on the spe-
cific node. The orange arrows indicate the dense layer with
weight W dself for the specific node self.
In analogy to pooling layers in convolutional neural net-
works, Graph Pooling is introduced by (Altae-Tran et al.
2017). Graph Polling is a simple operation that returns the
maximum activation across the node and its neighbours.
Simple illustration is shown in Figure . With graph pooling,
we could easily enlarge the receptive field without adding
extra weights. However, graph pooling does not change the
size of the graph as the pooling of CNN does to the features
of images.
Although there is no real convolution operation in graph
convolutional network, graph convolutional network is de-
sign for similar reason to convolutional neural network, the
’local geometry’ and reasonable weight sharing. Convolu-
tional networks(LeCun et al. 1998) apply convolutions to ex-
ploit the translation equivariance of image features. And the
feature learned form CNN is translation equivariant to some
extent. Graph convolutional network also focus on learning
local feature, through sharing weight with dense layers op-
erate on nodes with the same number of degree. Thus, the
feature learned by graph convolutional is determined by lo-
cal neighbours rather the global position of nodes. Such fea-
tures are equivariant to permutation of atomic group.
Dummy Super Node
Learning graph-level is a central problem of molecule classi-
fication and regression. Modern graph convolution networks
often contain two graph convolution layers and two graph
polling layers, the receptive field of the such model is too
small, especially compared with the size of most drug com-
pounds. Simply summing the node-level features can not en-
large the receptive of the model in a real sense. A naive way
to enlarge the receptive field is simply applying more graph
convolutional layers. However, such method makes model
more likely to overfit and perform worse in validation and
test subset for the lack of enough data in drug datasets.
In order to learn better graph-level representations, we
introduce a dummy super node that is connected with all
nodes in the graph by a directed edge, as the representa-
tion of the graph. Since the dummy super node is directly
connected with all nodes in graph, it can easily learn global
feature through one graph convolution layer. The directed
edge pointed to the dummy super node from other genuine
nodes, indicates that the dummy super node could learn fea-
tures from all other genuine nodes, while none of the gen-
uine nodes would be affected by the dummy super node.
Consequently, the dummy super node could learn the global
feature while the genuine nodes keep learning local features
that is equivariant to permutation of atomic group. Since the
feature of molecules is likely to be more complex than that
of atoms, we could use a longer vector as the feature of the
dummy super node.
Formally, we could formulate the new feature of the
dummy super node S′ of graph convolution layer as
S′ =WselfS +
∑
1≤i≤N
Wnbvi + b (2)
whereWself is the weight for the dummy super node,Wnb
is the weight for genuine node, N is the number of nodes,
vi is the feature of ith node, b is the bias. The dummy super
node S is initialized to zero and get updated through graph
convolutional networks simultaneously as the genuine nodes
do.
GC: Graph Convolution GP: Graph Pooling BN: Node-Level Batch Normalization
GC+RELU+BN GP GC+RELU+BN GP GC+RELU+BN Two-LayerClassifier
Figure 2: Our Network Structure. We apply three graph convolution blocks(GC + RELU + BN) and two graph pooling layers,
then we feed the feature of the dummy super node to a two-layer classifier. The batch normalization used here is node-level
batch normalization. The third graph convolution block only calculates the feature of the dummy super node, for the new feature
of other nodes would not be fed into following classifier.
The new features of genuine nodes are not affected by the
dummy super node, and keep the same as Equation 1. Graph
pooling is only applied to genuine nodes, and the dummy su-
per node is not regarded as neighbours of other nodes when
graph pooling is applied.
Network Structure
In addition to graph operations, we also apply node-level
batch normalization, relu activation, tanh activation and
dense layer in the model. For some datasets with imbalance
data, we replace common cross entropy loss with focal loss.
The whole network structure is shown in Figure . We add
the dummy super node and its edges to the original graph
before sending it to the network. In our model, We apply
three graph convolution blocks(GC + RELU + BN) and two
graph pooling layers, then we feed the feature of the dummy
super node to a two-layer classifier. The batch normalization
used there is node-level batch normalization that would be
discussed later. Only the feature of the dummy super node
is calculated in the third graph convolution block, for the
new feature of other nodes would not be fed into following
classifier.
Unlike the ResNet, we place relu activation before batch
normalization, for the experiment shows that it is hard to
train when we place relu activation behind. We argue that the
molecule feature is different from that of images. The noise
in images usually does not affect the image label, while that
in molecules not.
Node-Level Batch Normalization Since the number of
atoms vary from molecules, standard batch normaliza-
tion(Ioffe and Szegedy 2015) can not be applied to graph
convolution network directly. We extend standard batch nor-
malization to node-level batch normalization. We normalize
the feature of each node, make it zero mean and unit vari-
ance. Since the dummy super node is also a node, we simply
apply identical normalization to the dummy super node as
well.
Focal Loss Data in drug datasets is often unbalanced. Take
HIV dataset as instance, there are only 1487 chemical com-
pounds that are HIV active in the dataset of totally 41913
chemical compounds. However, previous work(Altae-Tran
et al. 2017; Wu et al. 2017) do not pay much attention to the
fact of unbalanced data in Drug dataset.
Downsample is a simple method to tackle with unbal-
anced data. However, the number of data in drug datasets
is always not large for the difficulty of acquiring data and
get them labeled, and simple downsample may result in se-
rious overfitting of neural network for the lack of sufficient
data. In addition, Boosting is an effective resample method
that may address imbalance data. But it’s not easy to inte-
grate boosting with deepchem(Wu et al. 2017), the modern
chemical machine learning framework.
Focal Loss is an elegant and brief proposal that introduced
by (Lin et al. 2017) to address class imbalance. It shows that
focal loss could effectively improve the performance of one-
stage detector in object detection. In fact, Focal Loss is a
kind of reshaped cross entropy loss that the weighs of well-
classified examples are reduced. Formally, Focal Loss is de-
fined as
FL(p) = −(y(1− p)γ log p+ (1− y)pγ log(1− p)).
where y ∈ {0, 1} specifies the ground-truth class, p ∈
[0, 1] is the model’s estimated probability for the class with
label y = 1, γ is tunable focusing parameter. When γ = 0,
focal loss is equivalent to cross entropy loss, and as γ is in-
creased the effect of the modulating factor is likewise in-
creased. Focal loss focuses on training on a sparse set of
hard examples and prevents the vast number of easy nega-
tives from overwhelming the classifier during training.
Experiment
We evaluate our model on several datasets of MoleculeNet,
ranging from drug activity, toxity, solvation. Our code is re-
leased in Github1.
MoleculeNet
MoleculeNet is a dataset collection built upon multiple pub-
lic databases, covering various levels of molecular proper-
ties, ranging from atomic-level properties to macroscopic in-
fluences on human body.
For chemical data, random splitting datasets into
train/valid/test collections that is widely used in machine
1https://github.com/microljy/graph_level_
drug_discovery
Table 1: The Performance in FreeSolv dataset. R2 is squared Pearson correlation coefficient(larger is better). Since R2 used
by (Wu et al. 2017) can not perfectly reflect the performance of the model, we provide with RMSE and MAE(kcal/mol) as well.
Model Split Method Valid Test
R2 RMSE MAE R2 RMSE MAE
GraphConv
Index 0.935 0.909 0.703 0.941 0.963 0.738
Random 0.928 0.982 0.644 0.895 1.228 0.803
Scaffold 0.883 2.115 1.555 0.709 2.067 1.535
Our
Index 0.952 0.787 0.566 0.945 0.933 0.598
Random 0.933 1.010 0.652 0.910 1.112 0.659
Scaffold 0.884 2.076 1.404 0.746 1.939 1.415
learning, is often not correct(Sheridan 2013). Consequently,
MoleculeNet implements multiple different splittings(Index
Split, Random Split, Scaffold Split) for each dataset. Scaf-
fold split attempts to separate structurally molecules in the
training/validation/test sets, thus the scaffold split offers a
greater challenge and demands a higher level of generaliza-
tion ability for learning algorithms than index split and ran-
dom split.
For quite a few datasets in MoleculeNet, the number of the
positive samples and the number of negative samples is not
balanced. Thus the accuracy metrics widely used in machine
learning classification tasks are not suitable here. In Molecu-
leNet, classification tasks are evaluated by area under curve
(AUC) of the receiver operating characteristic (ROC) curve,
and regression tasks are evaluated by squared Pearson cor-
relation coefficient (R2).
We pick following datasets(Tox21, ToxCast, HIV, MUV,
PCBA, FreeSolv) on macroscopic chemical influences on
human body from MoleculeNet, and evaluate our model.
Tox21 The Toxicology in the 21st Century (Tox21) initia-
tive created a public database measuring toxicity of com-
pounds, which has been used in the 2014 Tox21 Data Chal-
lenge(tox ). Tox21 contains qualitative toxicity measure-
ments for 8014 compounds on 12 different targets, including
stress response pathways and nuclear receptors.
ToxCast ToxCast is another data collection (from the
same initiative as Tox21) providing toxicology data for
a large library of compounds based on in virtual high-
throughput screening(Richard et al. 2016). The processed
collection in MoleculeNet contains qualitative results of
over 600 experiments on 8615 compounds.
MUV The MUV dataset(Rohrer and Baumann 2009) con-
tains 17 challenging tasks for around 90,000 compounds and
is specifically designed for virtual screening techniques. The
positives examples in these datasets are selected to be struc-
turally distinct from one another.
PCBA PubChem BioAssay (PCBA) is a database that con-
sists of biological activities of small molecules generated
by high-throughput screening(Wang et al. 2011). The pro-
cessed collection in MoleculeNet is a subset that contains
128 bioassays measured over 400,000 compounds.
HIV The HIV dataset was introduced by the Drug Ther-
apeutics Program (DTP) AIDS Antiviral Screen, which
tested the ability to inhibit HIV replication for 41,913 com-
pounds(hiv ). Screening results were evaluated and placed
into three categories: confirmed inactive (CI), confirmed
active (CA) and confirmed moderately active (CM). In
MoleculeNet, the latter two labels are combined, making it a
classification task between inactive (CI) and active (CA and
CM).
FreeSolv The Free Solvation Database (FreeSolv) pro-
vides experimental and calculated hydration free energy of
small molecules in water(Mobley and Guthrie 2014). Free-
Solv contains 643 compounds, a subset of which are also
used in the SAMPL blind prediction challenge(Mobley et
al. 2014).
Settings and Performance Comparisons
We apply the identical network to all above datasets, except
for the output channel number of the last layer that is deter-
mined by the number of tasks. For different datasets, we only
tune the hyperparameter of training. We compare our model
with logistic regression with ECFP feature as input and stan-
dard graph convolution network. To have a fair comparison,
we reimplement graph convolution network, and most of the
performance of our implements are much better than that re-
ported by (Wu et al. 2017).
Classification Tasks For classification tasks(Tox21, Tox-
Cast, MUV, PCBA), we utilize the area under curve (AUC)
of the ROC curve as metric(larger is better). The results are
shown in Table 2, Table 3, Table 5 and Table 4. Our model
generally surpasses standard graph convolution network and
conventional logistic regression in both small datasets on
toxity(Tox21, ToxCast) and larger datasets on bioactivi-
ties(MUV, PCBA). It indicates that our method could gener-
ally improve the performance of graph convolution network.
Compared with standard graph convolution network, in av-
erage, our model achieves an improvement of about 1.5% in
the test subset of the four datasets.
Regression Tasks For regression tasks(FreeSolv), we uti-
lize squared Pearson correlation coefficient(R2), RMSE,
MAE as metrics. The experimental results are shown in Ta-
ble 1. We only report the performance of graph convolution
network and our model here. Our model has a better perfor-
mance in general. We argue that our model failed to surpass
graph convolution network in validation subset under ran-
dom splitting for stochastic factors introduced by splitting
Table 2: The area under curve (AUC) of the ROC curve
of various models in Tox21 dataset.
Model Split Method Train Valid Test
ECFP+LR
Index 0.903 0.704 0.738
Random 0.901 0.742 0.755
Scaffold 0.905 0.651 0.697
GraphConv
Index 0.945 0.829 0.820
Random 0.938 0.833 0.846
Scaffold 0.955 0.778 0.752
Our
Index 0.965 0.839 0.848
Random 0.964 0.842 0.854
Scaffold 0.971 0.788 0.759
Table 3: The area under curve (AUC) of the ROC curve
of various models in ToxCast dataset.
Model Split Method Train Valid Test
ECFP+LR
Index 0.727 0.578 0.464
Random 0.713 0.538 0.557
Scaffold 0.717 0.496 0.496
GraphConv
Index 0.904 0.723 0.708
Random 0.901 0.734 0.754
Scaffold 0.914 0.662 0.640
Our
Index 0.927 0.747 0.734
Random 0.924 0.746 0.768
Scaffold 0.929 0.696 0.657
Table 4: The area under curve (AUC) of the ROC curve
of various models in PCBA dataset.
Model Split Method Train Valid Test
ECFP+LR
Index 0.809 0.776 0.781
Random 0.808 0.772 0.773
Scaffold 0.811 0.746 0.757
GraphConv
Index 0.895 0.855 0.851
Random 0.896 0.854 0.855
Scaffold 0.900 0.829 0.829
Our
Index 0.904 0.869 0.864
Random 0.899 0.863 0.867
Scaffold 0.907 0.847 0.845
Table 5: The area under curve (AUC) of the ROC curve
of various models in MUV dataset.
Model Split Method Train Valid Test
ECFP+LR
Index 0.960 0.773 0.717
Random 0.954 0.780 0.740
Scaffold 0.956 0.702 0.712
GraphConv
Index 0.951 0.816 0.792
Random 0.949 0.787 0.836
Scaffold 0.979 0.779 0.735
Our
Index 0.982 0.816 0.795
Random 0.989 0.800 0.845
Scaffold 0.990 0.816 0.762
method and too few numbers of compounds in FreeSolv.
It is interesting that how our method competes with clas-
sic ab-initio calculations. Hydration free energy that should
Table 6: The area under curve (AUC) of the ROC curve
of various models in HIV dataset. With focal loss(γ = 2),
our method achieves further improvement.
Model Split Method Train Valid Test
ECFP+LR
Index 0.864 0.739 0.741
Random 0.860 0.806 0.809
Scaffold 0.858 0.798 0.738
GraphConv
Index 0.945 0.779 0.728
Random 0.939 0.835 0.822
Scaffold 0.938 0.795 0.769
Our
Index 0.973 0.789 0.737
Random 0.951 0.842 0.830
Scaffold 0.967 0.813 0.763
Our + Focal Loss
Index 0.993 0.793 0.749
Random 0.993 0.843 0.851
Scaffold 0.992 0.816 0.776
be predicated in FreeSolv has been widely used as a test
of computational chemistry methods. With energy values
ranging from -25.5 to 3.4kcal/mol in the FreeSolv dataset,
the RMSE of ab-initio calculations results reach up to
1.5kcal/mol(Mobley et al. 2014). Our methods clearly out-
perform ab-initio calculations when we utilize index split
and random split. However, our method fails to outperform
ab-initio calculations when the dataset is split by scaffold
split that separate molecules structurally. We argue that it is
the insufficient data that results in weak generalization abil-
ity of our model. When fed with enough data, our model
may overall surpass classic ab-initio calculations.
imbalance Class We apply focal loss in HIV dataset that
have unbalanced class. The experimental results of Table
6 shown that focal loss could further improve the perfor-
mance. It is interesting that our model overfits quickly in
train dataset when we apply focal loss. We argue that focal
loss helps our model handle hard example and fit better in
train dataset.
Conclusion
In this paper, we point out that molecular properties pred-
ication demand graph-level representation. However, most
of the previous works on graph neural network only focus
on learning node-level representation. Such representation
is clearly not sufficient for molecular properties predication.
In order to learn graph-level representation, we propose the
dummy super node that is connected with all nodes in the
graph by a directed edge and modify the graph operation
to help the dummy super node learn graph-level feature.
Thus, we can handle graph-level classification and regres-
sion in the same way as node-level classification and re-
gression. The experiment on MoleculeNet shows that our
method could generally improve the performance of graph
convolution network.
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